Literature DB >> 320277

Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity.

J E Edwards, J Z Montgomerie, K Ishida, J O Morrison, L B Guze.   

Abstract

The ocular pathogenicity of species of Candida other than albicans was studied in the rabbit model of hematogenous candida endophthalmitis by injection of 10(5)-10(8) colony-forming units of Candida krusei, Candida parapsilosis, Candida guilliermondii, Candida tropicalis, Candida stellateoidea, and Candida albicans (control). At one and three weeks after infection, rabbits were examined by indirect ophthalmoscopy and were sacrificed for culture of eyes and kidneys. With an inoculum of 10(8) organisms, C. tropicalis and C. stellatoidea infected the kidneys but only occasionally infected the chorioretina and never infected the vitreous. Organisms were cultured only rarely from the kidneys of rabbits infected with C. krusei, C. guilliermondii, and C. parapsilosis; these species were never isolated from eyes. The C. albicans control consistently infected the kidney, chorioretina, and vitreous; approximately equal numbers of C. albicans were isolated from these organs. These data suggest a relative resistance of ocular tissues to hematogenous candida infections with species other than C. albicans.

Entities:  

Mesh:

Year:  1977        PMID: 320277     DOI: 10.1093/infdis/135.2.294

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Candidemia complicated by endophthalmitis: a prospective analysis.

Authors:  S Kannangara; D Shindler; D Y Kunimoto; B Sell; J A DeSimone
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

2.  Chemotherapy of experimental endogenous Candida albicans endophthalmitis.

Authors:  D B Jones
Journal:  Trans Am Ophthalmol Soc       Date:  1980

3.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

4.  Duration of treatment for candidemia and risk for late-onset ocular candidiasis.

Authors:  O Blennow; L Tallstedt; B Hedquist; B Gårdlund
Journal:  Infection       Date:  2012-12-02       Impact factor: 3.553

5.  Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity.

Authors:  E Anaissie; R Hachem; C K-Tin-U; L C Stephens; G P Bodey
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

6.  Adherence and penetration of vascular endothelium by Candida yeasts.

Authors:  S A Klotz; D J Drutz; J L Harrison; M Huppert
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.